account_id none on file
legal_name NovoCure Ltd
ticker NVCR
cik 1645113
domain novocure.com
linkedin_company_url https://www.linkedin.com/company/novocure-inc
entry_point_account_id none on file
name NovoCure Limited
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 1 filings 0 executives 9 family 0
why_nownone on file
calls
We believe our current funds available, coupled with diligent expense management, will provide the necessary bridge as we bring new revenue streams online. Therefore, we have decided not to go beyond the $200 million already drawn from our current credit facility.
Feb 26, 2026 / receipt, needs a key / Christoph Brackman, CFO | earnings call 2026-02-26 | transcript 1d3d6492-b338-4967-818b-ca4ed6e68187 | chars 13874-14138 | segment 14
filingsnone on file
executives
| Asaf Danziger | director | - | receipt |
| Ashley Cordova | Chief Financial Officer | - | receipt |
| Bill Doyle | CEO | - | receipt |
| Christoph Brackman | CFO | - | receipt |
| Christoph Brackmann | Chief Financial Officer | - | receipt |
| Frank Leonard | President | - | receipt |
| Jeryl Hilleman | director | - | receipt |
| Kristin Stafford | director | - | receipt |
| Wilco Groenhuysen | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-10-29 | earnings call | scheduled | ir |
changes
| 2025-12-01 | President, appointed | sec_8k |
| 2024-10-30 | Chief Financial Officer, appointed | sec_8k |
| 2024-09-03 | Chief Financial Officer, appointed | sec_8k |
| 2023-03-29 | director, appointed | sec_8k |
| 2022-06-10 | director, appointed | sec_8k |
| 2020-08-13 | Chief Financial Officer, appointed | sec_8k |
| 2020-06-12 | director, appointed | sec_8k |
mcp_package_hint
slug novocure-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$